feed,title,long_url,short_url
MarketWatch,Theravance Bio stock falls more than 20% after drug trial disappoints,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/0sNTw6CIl50/story.aspx,https://on.mktw.net/386747A
